Veracyte (VCYT) Invested Capital (2012 - 2026)

Veracyte (VCYT) has 15 years of Invested Capital data on file, last reported at $1.3 billion in Q1 2026.

• Quarterly Invested Capital rose 11.25% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 11.25% YoY) and the FY2025 annual result came in at $1.3 billion, up 9.89% from the prior year.
• Invested Capital rose to $1.3 billion in Q1 2026 per VCYT's latest filing, from $1.3 billion in the prior quarter.
• The five-year high for Invested Capital was $1.3 billion in Q1 2026, with the low at $1.0 billion in Q4 2023.
• Average Invested Capital over 5 years is $1.2 billion, with a median of $1.1 billion recorded in 2024.
• Year-over-year, Invested Capital retreated 5.3% in 2022 and advanced 13.97% in 2024.
• Veracyte's Invested Capital stood at $1.1 billion in 2022, then slipped by 2.75% to $1.0 billion in 2023, then increased by 13.97% to $1.2 billion in 2024, then increased by 9.89% to $1.3 billion in 2025, then increased by 2.63% to $1.3 billion in 2026.
• Business Quant data shows VCYT's Invested Capital at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.